Immunomodulation with Immunoglobulins for Autoimmune Diseases and Infections 1st Edition

0.0

The multiple possibilities for use of polyvalent immunoglobulins in autoimmune diseases, for prophylaxis and therapy for infections, including sepsis with immune paralysis, are remarkable. In 23 contributions specialist authors present: The immunomodulatory action of i.v. immunoglobulins for autoimmune diseases and infections The possible mechanisms of action of polyvalent immunoglobulins The broad spectrum of beneficial use of immunoglobulins in widely differing clinical disciplines Table of Contents Immunoglobulins:Possible Mechanisms of Action in Autoimmunity and Inflammation H.-D. Volk Modulation of T-Cell Function by the Use of New Forms of Therapy N. Utku Inhibition of Apoptosis Mechanisms by IVIG B. Volc-Platzer Clinical Use and Possible Mechanisms of Action of High-Dose, Intravenous Immunoglobulins for Autoimmune Diseases in Dermatology A. Rütter, T. Brozska, T. A. Luger Immunoglobulin Therapy for Atropic Dermatitis U. Rappen Aventis Behring's Integrated Safety System for the Production of Plasma-Derived Pharmaceuticals R. Johannsen, F. Niemann, Th. Weimer, H. Neidhardt 7S-Immunoglobulin (Venimmun® N) for ITP M. G. Kiehl Intravenous Immunoglobulin Therapy for Severe Forms of Rheumatoid Arthritis M. Keysser, U. Maaß Immunoadsorption Therapy and Administration of Immunoglobulins for Dilated Cardiomyopathy A. Staudt, G. Baumann, S. Felix High-Dose IVIG Therapy for Immune Neuropathies: Efficacy and Mechanisms of Action H.-P.Hartung, B. C. Kieseier, M. Stangel, J. J. Archelos Influence of Intravenous Immunoglobulins on Oligodendrocytes in Multiple Sclerosis and Experimental Encephalomyelitis: Protection from Cytotoxicity or Promotion of Remyelination? R. Gold, L. Schönrock, A. Weishaupt The Value of Immunoglobulins for Multiple Sclerosis F. Fazekas Special Aspects of Immunopathogenesis and Therapy in Multiple Sclerosis:Possible Roles of Intravenous Immunoglobulins F. Zipp, O. Aktas IVIG for Mitoxantrone-Resistant Multiple Sclerosis E. Mauch Mechanisms of Action of Intravenous Immunoglobulins on Oligodendrocytes: In Vitro Studies on Remyelination in Multiple Sclerosis M. Stangel, D. A. S. Compston Dermatomyositis/Polymyositis - Diagnostic Criteria and Therapeutic Aspects D. Pongratz, M. C. Walter Immunoglobulins for Myositides: Inclusion Body Myositis and Ocular Myositis A. Lindner, S. Zierz Intravenous Immunoglobulin G (IVIG) for Myasthenia Gravis:Short- and Long-Term Effects in Comparison to Other Immune Therapies V. Schuchardt Children Susceptible to Infections: Considerations on the Clarification of the Primary Immunodeficiencies and their Therapy with IVIG A. Böck Postoperative Immune Paralysis and Sepsis. Effectiveness of Intravenous Immunoglobulin (IVIG) Therapy. A Prospective Observation Study C. A. Jacobi, H. Zuckermann, W. Döcke, H. D. Volk, J. M. Müller Immunomodulation in Septic Alloplastic Implant Failure S. Albrecht, C. Gill Venimmun® in Stem Cell Support and Bone Marrow Transplantation (BMT) M. G. Kiehl, C. Müller Value of Infection Prophylaxis with Intravenous Immunoglobulins in Hemato-Oncology A. Glasmacher, I. Schmidt-Wolf